In agreement with previously published reports [12, 41], we were unable to seed our 4R Tau cell assay using seeds from Pick’s disease (data not shown) and, therefore, did not test the ability of antibody D to neutralize seeds from this disease. The gene discussed is MAPT; the disease is frontotemporal dementia.